6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Placement
Just now	Q3 FY26 Activities Report and Appendix 4C
Just now	FY26 Q1 Quarterly Activities Report and Appendix 4C
Just now	March 2026 Quarterly Activities & Cashflow Report
Just now	March 2026 Quarterly Activities Report and Appendix 4C

About

Relmada Therapeutics Inc (NASDAQ:RLMD) — investor relations, events, news, and company updates on 6ix.

Latest News

Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference

Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing

Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer

Financials

Revenue

$0

Market Cap

$733.18 M

EPS

-1.45

Community Chat

Ask AI